Serum binding of nifedipine and verapamil in patients with ischaemic heart disease on monotherapy.
Serum free fractions of nifedipine, verapamil and some of their metabolites were measured in patients with ischaemic heart disease receiving single oral dose and chronic monotherapy and were compared with those obtained in vitro. The percentages of unbound nifedipine and verapamil in vitro (concentration range 50-200 and 150-400 ng ml-1, respectively) were 2.51 and 7.23%, respectively, and did not differ from those found on monotherapy with these drugs (2.05 and 8.08%, respectively), and after single dosing. It is suggested that, during treatment with nifedipine or verapamil, their serum metabolites do not affect binding of the parent drugs to serum proteins.
Rumiantsev
D O
DO
Institute of Noncommunicable Disease Prevention, USSR Research Centre for Preventive Medicine, Moscow.
Piotrovskii
V K
VK
Metelitsa
V I
VI
Slastnikova
I D
ID
Martsevich SYu
Kokurina
E V
EV
D000328:Adult; D001798:Blood Proteins / Q000378:metabolism; D003327:Coronary Disease / Q000097:blood* / Q000188:drug therapy; D003956:Dialysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D009543:Nifedipine / Q000097:blood* / Q000627:therapeutic use; D011485:Protein Binding; D014700:Verapamil / Q000097:blood* / Q000627:therapeutic use
D001798:Blood Proteins; D014700:Verapamil; D009543:Nifedipine